尼曼-匹克C型杂合携带者的临床、眼动与影像学特征
研究纳入20例无症状的NPC1杂合携带者,评估运动、认知、嗅觉、睡眠及眼动功能,并行腹部超声和18F-FDG PET。结果显示携带者普遍存在NPC特征性眼动异常、肝脾肿大及认知损害,50%PET显示脑葡萄糖代谢减低,提示杂合变异可能与晚发性神经退行性变风险相关。
要点
- NPC1杂合携带者可出现NPC典型眼动异常及亚临床认知损害
- 肝脾肿大见于71%,胆甾烷三醇升高33%,血浆几丁质酶升高17%
- 50%携带者PET显示脑葡萄糖代谢减低,累及小脑、前扣带等区域
核心结论
- NPC1杂合携带状态与脑代谢异常及功能后果相关,可能是晚发性神经退行性变的风险因素,类似GBA杂合突变与帕金森病的概念。
研究设计与样本
- 研究纳入20例NPC患者的一级杂合亲属(13男,年龄52.7±9.9岁),评估运动、认知、情绪、睡眠和嗅觉,并行视频眼动图、腹部超声体积测定、血NPC生物标志物分析,16例行18F-FDG PET。
主要发现
- 杂合携带者重现了症状性NPC病的特征,并表现出NPC典型的眼动异常。
- 肝脾肿大见于71%,胆甾烷三醇升高见于33%,血浆几丁质酶升高见于17%。
- 嗅觉减退见于20%,REM睡眠行为障碍病理筛查阳性见于24%。
- 认知功能常受损,尤其影响视空间构造、言语流畅性和执行功能。
- PET显示50%参与者葡萄糖代谢率显著降低,累及小脑、前扣带、顶枕和颞区,其中1例为双侧异常。
临床怎么用
- 对NPC患者一级亲属进行杂合携带者评估时,应关注眼动、认知、嗅觉及睡眠障碍等亚临床标志。
- NPC1杂合携带者出现上述异常时,可考虑进一步行脑代谢影像评估。
局限性
- 样本量较小(20例,PET仅16例),未设对照组,结果需在更大队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize subclinical abnormalities in asymptomatic heterozygote NPC1 mutation carriers as markers of neurodegeneration. METHODS: Motor function, cognition, mood, sleep, and smell function were assessed in 20 first-degree heterozygous relatives of patients with Niemann-Pick disease type C (NPC) (13 male, age 52.7 ± 9.9 years). Video-oculography and abdominal ultrasound with volumetry were performed to assess oculomotor function and size of liver and spleen. NPC biomarkers in blood were analyzed. 18F-fluorodesoxyglucose PET was performed (n = 16) to detect patterns of brain hypometabolism. RESULTS: NPC heterozygotes recapitulated characteristic features of symptomatic NPC disease and demonstrated the oculomotor abnormalities typical of NPC. Hepatosplenomegaly (71%) and increased cholestantriol (33%) and plasma chitotriosidase (17%) levels were present. The patients also showed signs seen in other neurodegenerative diseases, including hyposmia (20%) or pathologic screening for REM sleep behavior disorder (24%). Cognitive function was frequently impaired, especially affecting visuoconstructive function, verbal fluency, and executive function. PET imaging revealed significantly decreased glucose metabolic rates in 50% of participants, affecting cerebellar, anterior cingulate, parieto-occipital, and temporal regions, including 1 with bilateral abnormalities. CONCLUSION: NPC heterozygosity, which has a carrier frequency of 1:200 in the general population, is associated with abnormal brain metabolism and functional consequences. Clinically silent heterozygous gene variations in NPC1 may be a risk factor for late-onset neurodegeneration, similar to the concept of heterozygous GBA mutations underlying Parkinson disease.
引用
- Bremova-Ertl T, Sztatecsny C, Brendel M, et al. Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity. Neurology. 2020. PMID: 32234823. doi:10.1212/WNL.0000000000009290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。